Literature DB >> 10425103

Synthesis and biological activity of (hydroxymethyl)- and (diethylaminomethyl)benzopsoralens.

A Chilin1, C Marzano, A Guiotto, P Manzini, F Baccichetti, F Carlassare, F Bordin.   

Abstract

Some benzopsoralens, carrying a hydroxymethyl or a diethylaminomethyl group at the 3, 5, 8, and 11 positions, were prepared, and their biological activity was compared with that of 4-(hydroxymethyl)benzopsoralen (BP). 5-(Hydroxymethyl)benzopsoralen (7b), 11-(hydroxymethyl)benzopsoralen (7c), and 11-(diethylaminomethyl)benzopsoralen (8c) induced marked antiproliferative effects in mammalian cells by simple incubation in the dark; this activity appeared to be related to their ability to inhibit topoisomerase II. Benzopsoralens appeared to be more active, especially BP and 7c, upon UVA activation. Compounds carrying a methyl group at the 4 position together with a hydroxymethyl or diethylaminomethyl at the 8 position (7d and 8d, respectively) were also effective, although to a lower extent; instead, a substituent at the 3 position canceled all activity. Benzopsoralens did not induce interstrand cross-links in DNA in vitro, as seen in the induction of cytoplasmic <<petite>> mutations and double-strand breaks in yeast. This behavior is also compatible with their low mutagenic activity in E. coli WP2 and with the absence of any phototoxicity on the skin. For these features, benzopsoralens seem to be interesting potential drugs for PUVA photochemotherapy and photopheresis. The activity shown in the dark is not sufficient for their possible use as antitumor drugs, but it does offer a new model for the study of topoisomerase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425103     DOI: 10.1021/jm991028s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Effects of psoralens as anti-tumoral agents in breast cancer cells.

Authors:  Maria Luisa Panno; Francesca Giordano
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.

Authors:  Ilaria Lampronti; Nicoletta Bianchi; Cristina Zuccato; Francesco Dall'Acqua; Daniela Vedaldi; Giampietro Viola; Rocco Potenza; Francesco Chiavilli; Giulia Breveglieri; Monica Borgatti; Alessia Finotti; Giordana Feriotto; Francesca Salvatori; Roberto Gambari
Journal:  Int J Hematol       Date:  2009-09-25       Impact factor: 2.490

Review 3.  New synthetic routes to furocoumarins and their analogs: a review.

Authors:  Valery F Traven
Journal:  Molecules       Date:  2004-02-28       Impact factor: 4.411

4.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.